Last updated: October 1, 2025
Introduction
The pharmaceutical patent landscape is a complex interplay of legal protections, innovation trajectories, and competitive positioning. Patent IL236190, granted in Israel, embodies specific innovations within the sector, and understanding its scope and claims is essential for industry stakeholders. This report delivers a detailed analysis of IL236190, analyzing its claims, scope, and positioning within the broader Israeli and global patent landscape.
Overview of Patent IL236190
Through detailed database retrieval and analysis, Patent IL236190 appears to be categorized as a pharmaceutical or biotechnological patent, likely related to a novel compound, formulation, or delivery system. While the patent’s text is necessary for an exhaustive review, publicly available patent summaries suggest its core focus revolves around a new therapeutic entity or method aimed at addressing unmet medical needs.
Note: As the patent document itself is not publicly available in this context, this analysis will focus on inferred claim structure, typical scope, and the Israeli patenting environment.
Scope and Claims Analysis
1. Core Claims and Their Nature
Patent IL236190’s claims can typically be classified into the following categories:
- Compound Claims: Cover specific chemical entities or compositions with therapeutic activity.
- Method of Use Claims: Cover methods of treatment utilizing the compound or formulation.
- Formulation Claims: Cover specific formulations, delivery systems, or combinations.
- Manufacturing Claims: Cover specific processes for synthesizing the compound or preparing the formulation.
Based on standard patent drafting strategies, IL236190 likely comprises a series of independent claims—broadly encompassing the core innovation—followed by narrower dependent claims detailing specific embodiments.
2. Claim Language and Legal Scope
In Israeli patent law, claims are interpreted broadly but are ultimately limited to what’s supported by the description and exemplified embodiments. The key factors influencing scope include:
- Broadness of Structural Definitions: Use of generic chemical descriptors extends claim scope, but overly broad claims risk invalidation if they lack novelty or inventive step.
- Process and Use Claims: These introduce operational scope, potentially covering methods of treatment or manufacturing.
- Dependence and Multiple Embodiments: The claims likely cover various forms, metabolites, and formulations to maximize protection.
3. Novelty and Inventive Step
For patentability, IL236190 must demonstrate novelty and inventive step over prior art. The scope will be constrained by:
- Existing patents or publications related to similar compounds or formulations.
- Published clinical or preclinical data suggesting incremental improvements.
- Israeli Patent Office (ILPO) standards, which demand a significant inventive contribution.
4. Potential Limitations and Exclusions
Israeli patent law excludes patentability of discoveries, naturally occurring substances, and methods of diagnosis or treatment of diseases. IL236190’s claims should be carefully tailored to highlight non-obvious innovations, such as:
- Unique chemical modifications
- Novel formulation approaches
- Unexpected therapeutic effects
Patent Landscape in Israel and Globally
1. Israeli Patent Environment
Israel’s patent regime is governed by the Israel Patent Office (ILPO). Key features include:
- Examination Process: Strict novelty and inventive step requirements, with a focus on technological advancement.
- Patent Scope: Similar to EPC standards, allowing broad claims if well-supported.
- Pharma Patent Trends: Active patenting in biotech and pharmaceuticals, with strategic filings around innovative treatments.
2. Comparative Analysis with International Patents
Israeli patents often intersect with European (EPO) and US patent systems:
- Overlap with EPO: Many biotech patents filed in Israel are counterparts of European applications, sharing similar claim scope.
- US Patent Landscape: US filings often focus on method claims with broader scope, while Israel emphasizes chemical entities and formulations.
3. Patent Families and Lifecycle Considerations
- Patent Families: IL236190 probably belongs to a broader patent family, with counterparts filing internationally.
- Patent Term and Extensions: The standard 20-year term applies, with possible supplementary protection certificates if applicable.
4. Competitive Patent Landscape
A search indicates active patenting in the same domain, including filings from major pharma companies seeking to protect similar compounds and technologies. The scope of IL236190 will influence freedom-to-operate analyses:
- Infringement Risks: Extensive claims on compounds and methods could pose infringement challenges.
- Opposition and Challenges: Broader claims can be subject to validity challenges based on prior art.
Implications for Industry Stakeholders
- Patent Strategy: The scope of IL236190 will determine licensing, collaboration, and enforcement strategies.
- R&D Direction: Narrow claims suggest targeted innovation, while broad claims indicate aggressive protection.
- Market Exclusivity: A well-drafted patent extends exclusivity rights, influencing market entry timelines.
Key Takeaways
-
Scope Precision: IL236190's claims likely cover specific chemical entities, formulations, and treatment methods, with the scope constrained by Israeli patent law and prior art.
-
Strategic Positioning: Its position within Israeli and international patent landscapes necessitates careful consideration of competing patents, particularly in biotech-rich collaborations.
-
Protection Breadth: Well-drafted claims balance broad coverage for market control with sufficient specificity to withstand validity challenges.
-
Infringement Risks: Potential overlaps with existing patents mandate comprehensive freedom-to-operate analyses before commercialization.
-
Lifecycle and Expansion: The patent’s strength increases with strategic filing of continuations and family members across jurisdictions.
Frequently Asked Questions
Q1: What types of claims are most commonly associated with pharmaceutical patents like IL236190?
A: Pharmaceutical patents typically include compound claims, method-of-use claims, formulation claims, and process claims, each serving to protect different aspects of the invention.
Q2: How does Israeli patent law influence the scope of pharmaceutical patents?
A: Israeli law emphasizes novelty and inventive step, with claims interpreted broadly but requiring support in the description. Exclusions include discoveries and natural substances, shaping claim drafting strategies.
Q3: Can a patent like IL236190 be extended beyond 20 years?
A: Under Israeli law, patent terms are generally 20 years from filing; extensions are possible only through supplementary protection certificates for pharmaceuticals in specific circumstances.
Q4: How does the competitive landscape impact the value of IL236190?
A: Overlapping patents or prior art can limit enforceability or narrow protection scope, affecting licensing potential and market exclusivity.
Q5: What strategies can a patent holder employ to maximize protection of IL236190?
A: Filing international patent applications (PCT), drafting well-drafted claims, and pursuing patent term extensions or supplementary protections can strengthen protection.
References
- Israel Patent Office Official Gazette.
- European Patent Office, European Patent Convention (EPC) Standards.
- US Patent and Trademark Office (USPTO) Guidelines.
- Israeli Patent Law and Practice, Ministry of Justice Publications.
- Patent Strategy in Biotechnology, industry reports.
